Skip to content

Clinical trials of the safety and efficacy of a soft hydrophilic contact lens (Model: DISC PM)

Clinical trials of the safety and efficacy of a soft hydrophilic contact lens (Model: DISC PM)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068846
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia

Interventions

Experimental group:Wear DISC PM soft contact lens
Control group :Wear monthly soft contact lens

Sponsors

Optometry Hospital Affiliated to Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.18=3:1; 4. The best corrected visual acuity of left and right main sense optometry is greater than or equal to 5.0 note 1 (equivalent to 1.0 decimal visual acuity); 5. Able to understand the purpose of the trial, willing to participate in the clinical trial and sign the informed consent

Exclusion criteria

Exclusion criteria: 1. Have a systemic disease that may affect the eyes, such as diabetes mellitus, Down syndrome, hyperthyroidism, rheumatoid arthritis, a history of sinusitis, or other diseases that are considered unsuitable for wearing contact lenses within 1 year before signing the informed consent; 2. Use any topical ophthalmic or systemic medications that may interfere with the fitting of the contact lens/require the lens to be removed during the day. Common drugs that affect vision include tricyclic depressants, phenothiazines, general anesthetics, immunomodulators, etc. 3. Suffered various eye diseases within 3 months before signing the informed consent, including but not limited to: Patients with acute or chronic ocular inflammation (chronic keratitis, chronic uveitis, chronic dacryocystitis, chronic blepharitis, iritis, seborrheic conjunctiva, etc.), glaucoma, corneal paresthesia, corneal epithelial defect, corneal endothelial cell depletion, cataract, keratoconus and irregular cornea, etc., should not be worn by researchers. 4. Dry eye injection (2) that is being used within 1 month prior to signing the informed consent or is planning to use drug intervention during the study period, and that the eye condition of the subject determined by the investigator is not suitable for wearing contact lenses in combination with recent drug use; Note 2: Drugs include drugs for dry eyes, such as artificial tears, calf serum extracts, non-steroidal anti-inflammatory drugs, etc. And the treatment of moderate and severe dry eye glucocorticoid, immunosuppressant and so on. 5. Patients with a history of ocular trauma or corneal surgery that affects the wearing of contact lenses; 6. Rupture time of tear film is less than or equal to 5s; 7. Abnormal intraocular pressure (intraocular pressure 21mmHg or binocular pressure difference > 5mmHg); 8. In any case where the researcher determines that the soft hydrophilic contact lens is not suitable for wearing, note 3; Note 3: In this clinical trial, the unsuitable conditions for wearing soft hydrophilic contact lenses are: (1) Eyelid abnormalities or infection; (2) Clinically significant slit-lamp findings (see Appendix 3 for details); (3) There are other active eye diseases. 9. The results of fundus examination do not meet the requirements of Appendix 3; 10. The results of corneal endothelial examination did not meet the requirements of Appendix 3; 11. Allergic patients who have used contact lenses, contact lens care products and/or fluorescein sodium stain strips; 12. People who wear soft hydrophilic contact lenses in special working or living environments such as dispersed dust, drugs, aerosol (such as hair spray, volatile chemicals) and dust for a long time; 13. Pregnant, lactating or planning to become pregnant at the time of inclusion; 14. Only one eye meets the entry criteria; 15. Unable to use the contact lens as required or unable to carry out regular eye examination; 16. Participants who have participated in other soft hydrophilic contact lens clinical trials within 1 week before signing the informed consent, or who have worn rigid breathable contact lenses or participated in other clinical trials (including rigid breathable contact lenses for orthokeratology) or concurrently participated in other clinical trials within 1 month before signing the informed consent; 17. Participants who have participated in drug clinical trials within 3 months before signing informed consent; 1

Design outcomes

Primary

MeasureTime frame
One week after wearing the glasses, the left and right eye contact lenses corrected vision;

Secondary

MeasureTime frame
The left and right eyes were corrected by contact lenses on the day, 1 month and 3 months;Optimal corrected visual acuity in the left and right eye frames on screening, the day of wearing glasses and for 3 months of wearing glasses;

Countries

China

Contacts

Public ContactJia Qu

Optometry Hospital Affiliated to Wenzhou Medical University

jiaqu@163.com+86 138 0689 8805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026